Lebwohl, M., Sugarman, J., Pariser, D., Bagel, J., Lin, T. and Israel, R. 2020. Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study. SKIN The Journal of Cutaneous Medicine. 4, 1 (Jan. 2020), S12.